Cargando…

Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease

OBJECTIVE: To study the protective effect of Echinacoside for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopaminergic (DA) neurons injury in the subacute mouse model of Parkinson's disease (PD) and to explore its mechanism of action. METHODS: We chose 10 weeks of healthy wild t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Yan, Chen, Chang, Xia, Baomei, Wu, Wei, Tang, Juanjuan, Chen, Qing, Tang, Lili, Yang, Hui, Zhang, Zhennian, Lu, Yan, Yang, Ye, Zhao, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374833/
https://www.ncbi.nlm.nih.gov/pubmed/30834264
http://dx.doi.org/10.1155/2019/4379639
_version_ 1783395247127003136
author Liang, Yan
Chen, Chang
Xia, Baomei
Wu, Wei
Tang, Juanjuan
Chen, Qing
Tang, Lili
Yang, Hui
Zhang, Zhennian
Lu, Yan
Yang, Ye
Zhao, Yang
author_facet Liang, Yan
Chen, Chang
Xia, Baomei
Wu, Wei
Tang, Juanjuan
Chen, Qing
Tang, Lili
Yang, Hui
Zhang, Zhennian
Lu, Yan
Yang, Ye
Zhao, Yang
author_sort Liang, Yan
collection PubMed
description OBJECTIVE: To study the protective effect of Echinacoside for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopaminergic (DA) neurons injury in the subacute mouse model of Parkinson's disease (PD) and to explore its mechanism of action. METHODS: We chose 10 weeks of healthy wild type C57BL/6 male mice, hypodermic MPTP 30 mg/kg/day, five days, to prepare PD subacute mouse model. Behavior indexes of open field test and pole test were applied to examine the function of ECH to PD subacute mice model of PD sample action. The effects of ECH on dopaminergic neurons and astrocyte were examined using Immunohistochemistry including tyrosine hydroxylase (TH) and glial fibrillary acidic protein (GFAP) expression. The total numbers of TH-positive neurons and GFAP-positive cells in the substantia nigra pars compacts (SNpc) and ventral tegmental area (VTA) were obtained stereologically using the optical fractionator method. Enzyme-linked immunosorbent assay (ELISA) method was used to detect the inflammatory cytokines in the serum, including TNF-α (Ttumor necrosis factor alpha) and IFN-γ (interferon gamma). Protein expressions of ionized calcium binding adaptor molecule 1 (IBA-1), TNF-α, Cleaved caspase-3, glial derived neurotrophic factor (GDNF), and phosphorylated and total extracellular signal-regulated kinase (p-ERK and ERK) in the anatomical region of substantia nigra (SN) were tested by protein immunoblot method (i.e., Western blotting). RESULTS: ECH reversed the reduction of total distance in open field test in MPTP-induced PD model mice (P < 0.01), shortened the return time and total time of PD subacute model mice in pole test (P < 0.01, P < 0.05), significantly reversed the reduction of TH positive neurons induced by MPTP (P < 0.05), and reduced the activation of astrocytes (P < 0.05). Meanwhile, ECH significantly inhibited the expression of IBA-1, Cleaved caspase-3, and TNF-α in midbrain of MPTP model mice (P < 0.05, P < 0.05, and P < 0.05) and upregulated the expression of GDNF (P < 0.05). And ECH lowered the level of TNF-α and IFN-γ in serum (P < 0.05, P < 0.05). CONCLUSION: ECH has protective effects on the MPTP subacute model mice, its mechanism may be through inhibiting activation of microglia and astrocytes, reducing inflammatory reaction and promoting the secretion of neurotrophic factors, and eventually resulting in the reduction of the DA neurons apoptosis.
format Online
Article
Text
id pubmed-6374833
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63748332019-03-04 Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease Liang, Yan Chen, Chang Xia, Baomei Wu, Wei Tang, Juanjuan Chen, Qing Tang, Lili Yang, Hui Zhang, Zhennian Lu, Yan Yang, Ye Zhao, Yang Biomed Res Int Research Article OBJECTIVE: To study the protective effect of Echinacoside for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopaminergic (DA) neurons injury in the subacute mouse model of Parkinson's disease (PD) and to explore its mechanism of action. METHODS: We chose 10 weeks of healthy wild type C57BL/6 male mice, hypodermic MPTP 30 mg/kg/day, five days, to prepare PD subacute mouse model. Behavior indexes of open field test and pole test were applied to examine the function of ECH to PD subacute mice model of PD sample action. The effects of ECH on dopaminergic neurons and astrocyte were examined using Immunohistochemistry including tyrosine hydroxylase (TH) and glial fibrillary acidic protein (GFAP) expression. The total numbers of TH-positive neurons and GFAP-positive cells in the substantia nigra pars compacts (SNpc) and ventral tegmental area (VTA) were obtained stereologically using the optical fractionator method. Enzyme-linked immunosorbent assay (ELISA) method was used to detect the inflammatory cytokines in the serum, including TNF-α (Ttumor necrosis factor alpha) and IFN-γ (interferon gamma). Protein expressions of ionized calcium binding adaptor molecule 1 (IBA-1), TNF-α, Cleaved caspase-3, glial derived neurotrophic factor (GDNF), and phosphorylated and total extracellular signal-regulated kinase (p-ERK and ERK) in the anatomical region of substantia nigra (SN) were tested by protein immunoblot method (i.e., Western blotting). RESULTS: ECH reversed the reduction of total distance in open field test in MPTP-induced PD model mice (P < 0.01), shortened the return time and total time of PD subacute model mice in pole test (P < 0.01, P < 0.05), significantly reversed the reduction of TH positive neurons induced by MPTP (P < 0.05), and reduced the activation of astrocytes (P < 0.05). Meanwhile, ECH significantly inhibited the expression of IBA-1, Cleaved caspase-3, and TNF-α in midbrain of MPTP model mice (P < 0.05, P < 0.05, and P < 0.05) and upregulated the expression of GDNF (P < 0.05). And ECH lowered the level of TNF-α and IFN-γ in serum (P < 0.05, P < 0.05). CONCLUSION: ECH has protective effects on the MPTP subacute model mice, its mechanism may be through inhibiting activation of microglia and astrocytes, reducing inflammatory reaction and promoting the secretion of neurotrophic factors, and eventually resulting in the reduction of the DA neurons apoptosis. Hindawi 2019-01-30 /pmc/articles/PMC6374833/ /pubmed/30834264 http://dx.doi.org/10.1155/2019/4379639 Text en Copyright © 2019 Yan Liang et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Liang, Yan
Chen, Chang
Xia, Baomei
Wu, Wei
Tang, Juanjuan
Chen, Qing
Tang, Lili
Yang, Hui
Zhang, Zhennian
Lu, Yan
Yang, Ye
Zhao, Yang
Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease
title Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease
title_full Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease
title_fullStr Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease
title_full_unstemmed Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease
title_short Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease
title_sort neuroprotective effect of echinacoside in subacute mouse model of parkinson's disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374833/
https://www.ncbi.nlm.nih.gov/pubmed/30834264
http://dx.doi.org/10.1155/2019/4379639
work_keys_str_mv AT liangyan neuroprotectiveeffectofechinacosideinsubacutemousemodelofparkinsonsdisease
AT chenchang neuroprotectiveeffectofechinacosideinsubacutemousemodelofparkinsonsdisease
AT xiabaomei neuroprotectiveeffectofechinacosideinsubacutemousemodelofparkinsonsdisease
AT wuwei neuroprotectiveeffectofechinacosideinsubacutemousemodelofparkinsonsdisease
AT tangjuanjuan neuroprotectiveeffectofechinacosideinsubacutemousemodelofparkinsonsdisease
AT chenqing neuroprotectiveeffectofechinacosideinsubacutemousemodelofparkinsonsdisease
AT tanglili neuroprotectiveeffectofechinacosideinsubacutemousemodelofparkinsonsdisease
AT yanghui neuroprotectiveeffectofechinacosideinsubacutemousemodelofparkinsonsdisease
AT zhangzhennian neuroprotectiveeffectofechinacosideinsubacutemousemodelofparkinsonsdisease
AT luyan neuroprotectiveeffectofechinacosideinsubacutemousemodelofparkinsonsdisease
AT yangye neuroprotectiveeffectofechinacosideinsubacutemousemodelofparkinsonsdisease
AT zhaoyang neuroprotectiveeffectofechinacosideinsubacutemousemodelofparkinsonsdisease